Androgen receptor binding sites identified by a GREF_GATA model.

Changes in transcriptional regulation can be permissive for tumor progression by allowing for selective growth advantage of tumor cells. Tumor suppressors can effectively inhibit this process. The PMEPA1 gene, a potent inhibitor of prostate cancer cell growth is an androgen-regulated gene. We addressed the question of whether or not androgen receptor can directly bind to specific PMEPA1 promoter upstream sequences. To test this hypothesis we extended in silico prediction of androgen receptor binding sites by a modeling approach and verified the actual binding by in vivo chromatin immunoprecipitation assay. Promoter upstream sequences of highly androgen-inducible genes were examined from microarray data of prostate cancer cells for transcription factor binding sites (TFBSs). Results were analyzed to formulate a model for the description of specific androgen receptor binding site context in these sequences. In silico analysis and subsequent experimental verification of the selected sequences suggested that a model that combined a GREF and a GATA TFBS was sufficient for predicting a class of functional androgen receptor binding sites. The GREF matrix family represents androgen receptor, glucocorticoid receptor and progesterone receptor binding sites and the GATA matrix family represents GATA binding protein 1-6 binding sites. We assessed the regulatory sequences of the PMEPA1 gene by comparing our model-based GREF_GATA predictions to weight matrix-based predictions. Androgen receptor binding to predicted promoter upstream sequences of the PMEPA1 gene was confirmed by chromatin immunoprecipitation assay. Our results suggested that androgen receptor binding to cognate elements was consistent with the GREF_GATA model. In contrast, using only single GREF weight matrices resulted in additional matches, apparently false positives. Our findings indicate that complex models based on datasets selected by biological function can be superior predictors as they recognize TFBSs in their functional context.

[1]  A. Brinkmann,et al.  The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells. , 2003, Biochemical and biophysical research communications.

[2]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[3]  A. Dress,et al.  Multiple DNA and protein sequence alignment based on segment-to-segment comparison. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Paredes,et al.  Testosterone Augments Neuronal Fos Responses to Estrous Odors throughout the Vomeronasal Projection Pathway of Gonadectomized Male and Female Rats , 1998, Hormones and Behavior.

[5]  Richard C. McEachin,et al.  Computationally Identifying Novel NF-κB-Regulated Immune Genes in the Human Genome , 2003 .

[6]  B. Frenkel,et al.  ChIP Display: novel method for identification of genomic targets of transcription factors. , 2004, Nucleic acids research.

[7]  M. Kritzer.  The distribution of immunoreactivity for intracellular androgen receptors in the cerebral cortex of hormonally intact adult male and female rats: localization in pyramidal neurons making corticocortical connections. , 2004, Cerebral cortex.

[8]  S. Arya,et al.  The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.

[9]  Jiannis Ragoussis,et al.  Quantitative high-throughput analysis of transcription factor binding specificities. , 2004, Nucleic acids research.

[10]  W. Wasserman,et al.  A predictive model for regulatory sequences directing liver-specific transcription. , 2001, Genome research.

[11]  Wei Zhang,et al.  PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. , 2003, Cancer research.

[12]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[13]  T. Werner,et al.  Computer modeling of promoter organization as a tool to study transcriptional coregulation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  P. Russell,et al.  Animal models of prostate cancer. , 2003, Methods in molecular medicine.

[15]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[16]  H. Juang.  Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3′,5′‐monosphosphate signal transduction pathway in human prostate carcinoma cells , 2004, The Prostate.

[17]  A. Sandelin,et al.  Applied bioinformatics for the identification of regulatory elements , 2004, Nature Reviews Genetics.

[18]  Martha L. Bulyk,et al.  Quantifying DNA–protein interactions by double-stranded DNA arrays , 1999, Nature Biotechnology.

[19]  D. Tindall,et al.  The role of the androgen receptor in prostate cancer. , 2002, Critical reviews in eukaryotic gene expression.

[20]  J. Lieb,et al.  ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments. , 2004, Genomics.

[21]  J W Moul,et al.  A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. , 2000, Genomics.

[22]  T. Werner,et al.  Regulatory context is a crucial part of gene function. , 2002, Trends in genetics : TIG.

[23]  S. Breedlove,et al.  Both estrogen receptors and androgen receptors contribute to testosterone-induced changes in the morphology of the medial amygdala and sexual arousal in male rats , 2003, Hormones and Behavior.

[24]  K. Porkka,et al.  Cloning and Characterization of a Novel Six-Transmembrane Protein STEAP2, Expressed in Normal and Malignant Prostate , 2002, Laboratory Investigation.

[25]  C. Sonnenschein,et al.  Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  D. Botstein,et al.  Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF , 2001, Nature.

[27]  Burkhard Morgenstern,et al.  DIALIGN: multiple DNA and protein sequence alignment at BiBiServ , 2004, Nucleic Acids Res..

[28]  D. Labuda,et al.  International Congress on Hormonal Steroids and Hormones and Cancer Prostate cancer susceptibility genes: lessons learned and challenges posed , 2003 .

[29]  Thomas Werner,et al.  Functional promoter modules can be detected by formal models independent of overall nucleotide sequence similarity , 1999, Bioinform..

[30]  P. Bucher,et al.  High-throughput SELEX–SAGE method for quantitative modeling of transcription-factor binding sites , 2002, Nature Biotechnology.

[31]  Wei Zhang,et al.  Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells , 2002, Oncogene.

[32]  J. Moul,et al.  Quantitative expression profile of androgen‐regulated genes in prostate cancer cells and identification of prostate‐specific genes , 2001, International journal of cancer.

[33]  T. Werner.  The promoter connection , 2001, Nature Genetics.

[34]  Martin Vingron,et al.  Functional inference from non-random distributions of conserved predicted transcription factor binding sites , 2004, ISMB/ECCB.

[35]  K. Grzeschik,et al.  Chromosomal localization to 3q21----qter and two TaqI RFLPs of the human prostate-specific acid phosphatase gene (ACPP). , 1989, Cytogenetics and cell genetics.

[36]  J. Moul.  Contemporary hormonal management of advanced prostate cancer. , 1998, Oncology.

[37]  Rongxiang Liu,et al.  Computationally identifying novel NF-kappa B-regulated immune genes in the human genome. , 2003, Genome research.

[38]  Alexander E. Kel,et al.  COMPEL: a database on composite regulatory elements providing combinatorial transcriptional regulation , 2000, Nucleic Acids Res..

[39]  Bernard A. Roos,et al.  A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer , 2000, Molecular and Cellular Endocrinology.

[40]  H. Lilja,et al.  Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen. , 2004, Genomics.